Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Atelerix
Atelerix
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Media
Atelerix secures Innovate UK funding for cell transport tech
The funding will support the development of room temperature technologies for shipping therapeutic cells, as part of the company’s ‘BloodReady’ project
Research & Development
Atelerix receives Innovate UK grant for cell therapy preservation hydrogel
The hydrogel tech increases shelf-life between 4°C and 25°C, increasing treatment flexibility as well as widening manufacturing options and driving down cost
Finance
ManChem funding roundup
This week has shown there is more than one way to innovate in the cutting-edge pharmaceutical realm
Subscribe now